First-line ceritinib versus platinum-based chemotherapy in advanced ALK-rearranged non-small-cell lung cancer (ASCEND-4): a randomised, open-label, phase 3 study.
| Image |  |
|---|---|
| Description | scientific article published on 23 January 2017 |
| Author/s |
author: Sergey Orlov Chong-Jen Yu Denis Moro-Sibilot Gilberto de Castro Diego Cortinovis Yi-Long Wu Alexis B Cortot |
| Publication date | January 24, 2017 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |